Xuehong Ran

High‐dose dexamethasone plus recombinant human thrombopoietin vs high‐dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial

Yafei Yu, Miaomiao Wang, Yu Hou et al. · American Journal of Hematology · 2020 · 61 citations · Full text

Medicine, Hematology, Pharmacology +8

A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia

Hai Zhou, Ping Qin, Qiang Liu et al. · American Journal of Hematology · 2019 · 52 citations · Full text

Medicine, Hematology, Pharmacotherapy +12

The RCAN1 inhibits NF-κB and suppresses lymphoma growth in mice

Chengzhen Liu, Libo Zheng, Hongliang Wang et al. · Cell Death and Disease · 2015 · 31 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

Comparison of acalabrutinib plus obinutuzumab, ibrutinib plus obinutuzumab and venetoclax plus obinutuzumab for untreated CLL: a network meta-analysis

Zhixin Sheng, Shilei Song, Miao Yu et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 24 citations

Medicine, Pharmacology, Pharmacotherapy +10

Comparable survival outcomes in HLA-Matched and haploidentical hematopoietic stem cell transplantation for severe aplastic anemia patients aged 40–50: A CBMTR Registry-based propensity score matching analysis over the last decade

Zhengli Xu, Yuping Zhang, Baodong Ye et al. · Cancer Letters · 2025 · 12 citations

Medicine, Hematology, Stem Cell Transplantation +15